Evidence map›Paper›PMID 28711865›Full record

ArticleJournal of the American Heart Association2017

Enhanced Mitochondrial Transient Receptor Potential Channel, Canonical Type 3-Mediated Calcium Handling in the Vasculature From Hypertensive Rats.

Bin Wang, Shiqiang Xiong, Shaoyang Lin, Weijie Xia, Qiang Li, Zhigang Zhao, Xing Wei, Zongshi Lu, Xiao Wei, Peng Gao and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 45 citations in OpenAlex.

  1. The role of IPPflugers Archiv : European journal of physiology · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Protective Role of TRPC3 Gene Polymorphism (rs10518289) in Obstructive Sleep Apnea Hypopnea Syndrome Among Hypertensive Patients.Medical science monitor : international medical journal of experimental and clinical research · 2024
    Article
  7. Review
  8. Mitochondria in health, disease, and aging.Physiological reviews · 2023
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Translational cancer research · 2022
    Article
  16. Role of store-operated Ca2+ entry in cardiovascular disease.Cell communication and signaling : CCS · 2022
    Review
  17. Review
  18. Review
  19. TRPC and TRPV Channels' Role in Vascular Remodeling and Disease.International journal of molecular sciences · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Bin WangCenter for Hypertension and Metabolic Diseases, Department of Hypertension and Endocrinology, Daping Hospital, Third Military Medical University Chongqing Institute of Hypertension, Chongqing, China.
Shiqiang XiongCenter for Hypertension and Metabolic Diseases, Department of Hypertension and Endocrinology, Daping Hospital, Third Military Medical University Chongqing Institute of Hypertension, Chongqing, China.
Shaoyang LinCenter for Hypertension and Metabolic Diseases, Department of Hypertension and Endocrinology, Daping Hospital, Third Military Medical University Chongqing Institute of Hypertension, Chongqing, China.
Weijie XiaCenter for Hypertension and Metabolic Diseases, Department of Hypertension and Endocrinology, Daping Hospital, Third Military Medical University Chongqing Institute of Hypertension, Chongqing, China.
Qiang LiCenter for Hypertension and Metabolic Diseases, Department of Hypertension and Endocrinology, Daping Hospital, Third Military Medical University Chongqing Institute of Hypertension, Chongqing, China.
Zhigang ZhaoCenter for Hypertension and Metabolic Diseases, Department of Hypertension and Endocrinology, Daping Hospital, Third Military Medical University Chongqing Institute of Hypertension, Chongqing, China.
Xing WeiCenter for Hypertension and Metabolic Diseases, Department of Hypertension and Endocrinology, Daping Hospital, Third Military Medical University Chongqing Institute of Hypertension, Chongqing, China.
Zongshi LuCenter for Hypertension and Metabolic Diseases, Department of Hypertension and Endocrinology, Daping Hospital, Third Military Medical University Chongqing Institute of Hypertension, Chongqing, China.
Xiao WeiCenter for Hypertension and Metabolic Diseases, Department of Hypertension and Endocrinology, Daping Hospital, Third Military Medical University Chongqing Institute of Hypertension, Chongqing, China.
Peng GaoCenter for Hypertension and Metabolic Diseases, Department of Hypertension and Endocrinology, Daping Hospital, Third Military Medical University Chongqing Institute of Hypertension, Chongqing, China.
Daoyan LiuCenter for Hypertension and Metabolic Diseases, Department of Hypertension and Endocrinology, Daping Hospital, Third Military Medical University Chongqing Institute of Hypertension, Chongqing, China daoyanliu@yahoo.com zhuzm@yahoo.com.
Zhiming ZhuCenter for Hypertension and Metabolic Diseases, Department of Hypertension and Endocrinology, Daping Hospital, Third Military Medical University Chongqing Institute of Hypertension, Chongqing, China daoyanliu@yahoo.com zhuzm@yahoo.com.
Daping Hospital · CNArmy Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMitochondrial Ca METHODS AND

resultsIn this study we demonstrated increased TRPC3 expression in purified mitochondria in the vasculature from SHRs, which facilitates enhanced mitochondrial calcium uptake and ROS generation compared with Wistar-Kyoto rats. Furthermore, inhibition of TRPC3 by its specific inhibitor, Pyr3, significantly decreased the vascular mitochondrial ROS production and H

conclusionsTogether, we give experimental evidence for a potential mechanism by which enhanced TRPC3 activity at the cytoplasmic and mitochondrial levels contributes to redox signaling and calcium dysregulation in the vasculature from SHRs. Angiotensin II or telmisartan can regulate [Ca

Indexed as

Calcium SignalingAdenosine TriphosphateAngiotensin II Type 1 Receptor BlockersAnimalsAntihypertensive AgentsBenzimidazolesBenzoatesBlood PressureCalciumCells, CulturedDisease Models, AnimalEnergy MetabolismHypertensionMaleMice, KnockoutMitochondriaAdenosine TriphosphateAngiotensin II Type 1 Receptor BlockersAntihypertensive AgentsBenzimidazolesBenzoatesCalciumReactive Oxygen SpeciesTelmisartanTRPC3 cation channelTRPC Cation Channelsmitochondriapyruvate dehydrogenasetelmisartantransient receptor potential channel, canonical type 3vasoconstriction

Identifiers

PMID28711865
PMCPMC5586301
OpenAlexW2735151383

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.